Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-19

Clinical Trial Update: Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing musculoskeletal ultrasound as a measure of therapeutic response to tofacitinib in rheumatoid arthritis patients; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tofacitinib (tofacitinib)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2019-03-19